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Abstract
Introduction: Arterial concentrations of carbon dioxide (PaCO2) and oxygen (PaO2) during admission to the
intensive care unit (ICU) may substantially affect organ perfusion and outcome after cardiac arrest. Our aim was to
investigate the independent and synergistic effects of both parameters on hospital mortality.
Methods: This was a cohort study using data from mechanically ventilated cardiac arrest patients in the Dutch
National Intensive Care Evaluation (NICE) registry between 2007 and 2012. PaCO2 and PaO2 levels from arterial
blood gas analyses corresponding to the worst oxygenation in the first 24 h of ICU stay were retrieved for analyses.
Logistic regression analyses were performed to assess the relationship between hospital mortality and both
categorized groups and a spline-based transformation of the continuous values of PaCO2 and PaO2.
Results: In total, 5,258 cardiac arrest patients admitted to 82 ICUs in the Netherlands were included. In the first 24
h of ICU admission, hypocapnia was encountered in 22 %, and hypercapnia in 35 % of included cases. Hypoxia and
hyperoxia were observed in 8 % and 3 % of the patients, respectively. Both PaCO2 and PaO2 had an independent
U-shaped relationship with hospital mortality and after adjustment for confounders, hypocapnia and hypoxia were
significant predictors of hospital mortality: OR 1.37 (95 % CI 1.17–1.61) and OR 1.34 (95 % CI 1.08–1.66). A
synergistic effect of concurrent derangements of PaCO2 and PaO2 was not observed (P = 0.75).
Conclusions: The effects of aberrant arterial carbon dioxide and arterial oxygen concentrations were
independently but not synergistically associated with hospital mortality after cardiac arrest.
Introduction
Even after successful resuscitation and return of spon-
taneous circulation (ROSC), cardiac arrest carries a poor
prognosis with limited options for treatment [1, 2]. In
addition to controlling temperature after cardiac arrest,
optimizing ventilation and oxygenation may improve
outcome [3]. International consensus currently recom-
mends careful monitoring of post-resuscitation ventila-
tion for neurological and cardiovascular outcome [4].
Indeed, targeting safe levels of carbon dioxide and oxygen
in arterial blood may limit global ischemic damage and
enhance oxygenation and blood flow. Aberrant arterial
levels have repeatedly been shown to be associated with
worse outcome after cardiac arrest, but the effects may de-
pend on degree and duration of the (concurrent) exposure
[5–14]. Recently, a large cohort study was performed in
125 intensive care units (ICUs) in Australia and New
Zealand, which showed that abnormal concentrations
of arterial carbon dioxide (PaCO2) were common
after cardiac arrest [15]. Compared with normocapnia,
hypocapnia was independently associated with worse
clinical outcomes, whereas hypercapnia was associated
with a greater likelihood of good outcome. The results were
reproduced in a smaller cohort [16] and are supported by
pediatric [17] and experimental research [18–20]. However,
ventilation and oxygenation are closely related and effects
of PaCO2 may not be independent from arterial oxygen
levels (PaO2). In this study, we aimed to investigate the
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separate and combined effects of both parameters in
a multicenter cohort of patients admitted to Dutch
ICUs after cardiac arrest.
Methods
Data collection
Analyses were performed on patient data retrieved from
82 ICUs of teaching and non-teaching hospitals partici-
pating in the Dutch National Intensive Care Evaluation
(NICE) registry between 2007 and 2012. The NICE
registry is a high quality ICU database, which is subject
to multiple quality checks and local audits in accordance
with applicable research and ethical protocols [21]. In
brief, the registry contains all clinical data required to
calculate mortality risk predictions according to, among
others, the Acute Physiology and Chronic Health Evalu-
ation (APACHE) IV for all consecutive ICU patients.
The registry does not contain variables determining the
cause and circumstances of the cardiac arrest and resus-
citation. For the analyses, data obtained from routine
care and without patient identifying information were
used and consent was therefore not needed according to
the Dutch Personal Data Protection Act.
In 2012, approximately 90 % of all Dutch ICUs
recorded the data for their patients in the registry. In
accordance with the previously conducted study by
Schneider et al. [15], all adult patients admitted after
out-of-hospital cardiac arrest were included. Abstracted
data included demographics, comorbidities, arterial blood
gas parameters, diagnostic and physiologic information,
admission source and illness severity score by means of
the APACHE IV.
Data extraction
Adult patients admitted to the ICU after out-of-hospital
cardiac arrest and cardiopulmonary resuscitation, who
were mechanically ventilated at any moment in the first
24 h of admission, were included. We excluded readmis-
sions, trauma patients, nonventilated patients and records
not meeting APACHE IV criteria.
As part of the NICE data collection, arterial blood gas
(ABG) parameters that were associated with the lowest
PaO2 to FiO2 ratio in the first 24 h after admission were
automatically extracted and subsequently used for classifi-
cation of patients. The APACHE IV score was recalculated
(AP4-adj) by standardizing the PaCO2 and PaO2 to fixed
normal values (40 mmHg and 80 mmHg, respectively) in
order to prevent overadjustment of these variables in the
multivariate models.
Statistical analysis
Univariate and multivariate logistic generalized estimating
equation (GEE) regression models, which account for
potential correlation of outcome within ICUs, were used
to examine the relationship between the primary outcome
(hospital mortality) and either PaCO2 or PaO2. The rela-
tionship of PaCO2 and PaO2 with mortality was plotted in
order to inspect the dose–response curve. Considering
the nonlinear relationships, the associations were analyzed
by modeling each of PaCO2 and PaO2 as a restricted cubic
spline and separately in categorized groups [22]. PaCO2
was categorized in three groups, using conventional
thresholds (normocapnia: 35–45 mmHg). PaO2 was cate-
gorized according to thresholds from previous studies
(normoxia: 60–300 mmHg) [5, 7–9, 23, 24]. The individ-
ual, joint and interaction effects of two-sided derange-
ments were separately investigated, as suggested for
cohort studies [25]. For a further understanding of the
dose–response relationship in multivariate models, PaO2
categories were also reanalyzed with alternative thresholds
derived from observation percentiles or previously used
targets [5, 7, 8, 26]. Variables extracted from the first 24 h
of admission were considered for the multivariate etio-
logical model based on clinical relevance and in accord-
ance with a previously used model [15]. Considered
covariates were introduced separately to the univariate
models in order to estimate the unadjusted effect and in-
cluded age, gender, AP4-adj, year of admission, admission
source, therapeutic hypothermia and lowest glucose as a
possible proxy-marker of less attentive care [24]. Covari-
ates were subsequently identified as confounders for the
outcome using the 10 % change-in-estimate method [27].
Hence, the final multivariate GEE models consisted of age,
lowest glucose, AP4-adj and either PaCO2 or PaO2. Col-
linearity among the covariates was inspected by estimating
Pearson or Spearman correlation coefficients as appropri-
ate. Routine temperature correction of arterial blood gas
results is uncommon in Dutch ICUs and was performed
according to the participating site’s practice. To account
for multiple testing, the statistical significance level for the
P-value was set at 0.01.
All analyses were conducted using SPSS version 21
(IBM Corp, Armonk, NY, USA) and R version 3.0.1
(R Foundation for Statistical Computing, Vienna, Austria).
Results
Data from 6,496 out-of-hospital cardiac arrest patients
and 82 hospitals were extracted from the NICE registry
and screened for enrollment (Additional file 1: Figure
S1). The main reasons for exclusion were no mechanical
ventilation (n = 196), missing valid ABG data (n = 379)
and not fulfilling APACHE IV criteria (n = 314).
Descriptive characteristics of the 5,258 included
patients are summarized in Table 1. The median age was
66 (interquartile range [IQR] 56–76) and patients were
predominantly male (69.6 %). Median PaCO2 was 42
mmHg (IQR 36–49) and median PaO2 was 92 mmHg
(IQR 75–124). Of all patients, 21.6 % were classified as
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Table 1 Descriptive characteristics
Characteristic All patients PaCO2 group PaO2 group
Hypocapnia Normocapnia Hypercapnia P value Hypoxia Normoxia Hyperoxia P value
No. (%) of patients 5258 1136 (21.6) 2288 (43.5) 1834 (34.9) 418 (8.0) 4696 (89.3) 144 (2.7)
Baseline characteristics
Age (years) 66 (56–76) 68 (56–77) 66 (56–76) 65 (55–74) <0.001 69 (57–78) 66 (56–75) 67 (56–77) 0.02
Male gender, n (%) 3661 (69.6) 737 (64.9) 1601 (70.0) 1323 (72.1) <0.001 294 (70.3) 3269 (69.6) 98 (68.1) 0.87
Admission source, n (%)
Operating room from emergency room same hospital 182 (3.5) 32 (2.8) 95 (4.2) 55 (3.0) 0.05 14 (3.3) 166 (3.5) 2 (1.4) 0.38
Emergency room same hospital 4578 (87.1) 981 (86.4) 1972 (86.2) 1625 (88.6) 0.05 367 (87.8) 4077 (86.8) 134 (93.1) 0.08
Operating room from emergency room other hospital 4 (0.1) 1 (0.1) 1 (<0.1) 2 (0.1) 0.74 0 4 (0.1) 0 0.79
Emergency room other hospital 183 (3.5) 41 (3.6) 81 (3.5) 61 (3.3) 0.90 16 (3.8) 166 (3.5) 1 (0.7) 0.17
Home 311 (5.9) 81 (7.1) 139 (6.1) 91 (5.0) 0.05 21 (5.0) 283 (6.0) 7 (4.9) 0.61
Acute renal failure, n (%) 660 (12.6) 154 (13.6) 242 (10.6) 264 (14.4) <0.001 79 (18.9) 565 (12.0) 16 (11.1) <0.001
Chronic co-morbidities, n (%)
Cardiovascular disease 380 (7.2) 94 (8.3) 158 (6.9) 128 (7.0) 0.30 30 (7.2) 340 (7.2) 10 (6.9) 0.99
Renal disease 319 (6.1) 87 (7.7) 137 (6.0) 95 (5.2) 0.04 24 (5.7) 287 (6.1) 8 (5.6) 0.91
Respiratory disease 225 (4.3) 33 (2.9) 72 (3.1) 120 (6.5) <0.001 26 (6.2) 191 (4.1) 8 (5.6) 0.08
Cirrhosis 44 (0.8) 16 (1.4) 14 (0.6) 14 (0.8) 0.05 9 (2.2) 35 (0.7) 0 <0.01
Cancer 106 (2.0) 25 (2.2) 48 (2.1) 33 (1.8) 0.62 6 (1.4) 96 (2.0) 4 (2.8) 0.57
Markers of severity,
APACHE IV score 117.3 (29.69) 117.5 (29.10) 114.6 (30.52) 120.4 (28.68) <0.001 132.2 (29.22) 115.9 (29.47) 119.5 (26.21) <0.001
APACHE IV risk of death 80.7 (65.3-90.0) 81.2 (66.2-90.2) 79.2 (63.0-89.2) 82.5 (68.2-91.1) <0.001 88.8 (78.1-94.0) 79.8 (64.3-89.4) 81.9 (64.9-89.4) <0.001
Physiological parameters obtained within the first 24 h in the intensive care unit
Temperature
Highest temperature (°C) 35.7 (34.8-36.9) 35.8 (34.7-37.0) 35.7 (34.8-36.8) 35.8 (34.8-36.9) 0.37 35.7 (34.6-37.1) 35.7 (34.8-36.9) 35.9 (34.9-36.8) 0.88
Lowest temperature (°C) 32.5 (31.8-33.2) 32.4 (31.8-33.4) 32.5 (31.9-33.2) 32.5 (31.9-33.3) 0.55 32.5 (31.8-33.6) 32.5 (31.8-33.2) 32.4 (31.7-33.3) 0.78
Lowest temperature below 34 °C, n (%) 4229 (80.4) 888 (78.2) 1863 (81.4) 1478 (80.6) 0.08 326 (78.0) 3788 (80.7) 115 (79.9) 0.41
Heart Rate
Highest heart rate, beats/min 103 (87–120) 102 (85–120) 101 (86–119) 105 (90–122) <0.001 110 (91–128) 102 (87–120) 105 (88–125) <0.001
Lowest heart rate, beats/min 55 (45–68) 55 (45–69) 53 (44–65) 55 (45–70) <0.001 55 (45–74) 55 (45–67) 51 (42–67) 0.11
Blood pressure (BP)
Highest systolic BP (mmHg) 150 (134–171) 150 (134–170) 150 (134–172) 150 (133–170) 0.61 145 (128–165) 150 (134–172) 156 (139–178) <0.001











Table 1 Descriptive characteristics (Continued)
Respiratory rate (RR)
Highest RR, breaths (min) 23 (20–28) 23 (19–29) 23 (19–28) 24 (20–29) <0.001 25 (20–30) 23 (20–28) 23 (19–28) <0.01
Lowest RR, breaths (min) 14 (12–16) 14 (12–16) 14 (11–16) 14 (12–17) 0.03 15 (12–18) 14 (12–16) 14 (12–16) <0.001
Oxygenation
PaO2 (mmHg) 92 (75–124) 99 (78–136) 94 (76–125) 87 (70–116) <0.001 51 (44–56) 94 (78–124) 359 (320–438) <0.001
FiO2 (%) 50 (40–70) 45 (40–60) 50 (40–62) 60 (44–90) <0.001 66 (50–100) 50 (40–70) 98 (67–100) <0.001
PaO2/FiO2 ratio 191 (124–272) 227 (157–316) 203 (134–283) 158 (100–228) <0.001 71 (55–100) 198 (136–272) 440 (361–550) <0.001
Carbon dioxide
PaCO2 (mmHg) 42 (36–49) 31 (28–33) 40 (38–43) 52 (48–59) <0.001 45 (38–54) 41 (35–48) 40 (34–48) <0.001
Metabolic
Lowest glucose (mmol l−1) 6.0 (4.8-7.4) 5.9 (4.8-7.3) 6.0 (4.8-7.3) 6.1 (4.8-7.5) 0.65 6.2 (4.8-7.9) 6.0 (4.8-7.3) 6.1 (5.0-7.8) 0.13
Acid–base balance
Lowest pH 7.28 (0.12) 7.37 (0.11) 7.30 (0.10) 7.20 (0.12) <0.001 7.24 (0.14) 7.29 (0.12) 7.26 (0.14) <0.001
Highest HCO3 - (mmol l
−1) 22.3 (3.92) 20.8 (3.67) 22.1 (3.54) 23.5 (4.16) <0.001 22.8 (4.70) 22.3 (3.85) 22.0 (3.89) 0.43
Lowest HCO3 - (mmol l
−1) 17.4 (4.33) 16.0 (4.17) 17.4 (4.03) 18.3 (4.54) <0.001 16.6 (4.96) 17.5 (4.27) 17.2 (4.10) <0.01
Data presented as total number (percentage), mean (standard deviation) or median (interquartile range) depending on underlying data distribution
P-values for group comparisons using ANOVA or Kruskal-Wallis according to data distribution











hypocapnic, 43.5 % as normocapnic and 34.9 % as hyper-
capnic. Patients were further classified as hypoxic (8 %),
normoxic (89.3 %) or hyperoxic (2.7 %). The majority of
patients (87.4 %) were admitted to the ICU from the
emergency room of the same hospital. The unadjusted
mean APACHE IV score was 117.3, with the normocap-
nia and the normoxia groups showing the lowest mean
(P < 0.001). Groups were relatively balanced in terms of
admission source, comorbidities, temperature, glucose
and non-respiratory markers.
Unadjusted outcome
Table 2 shows the unadjusted mortality rates. Overall,
2,491 (47.4 %) patients died in the ICU and 2,833 (53.9 %)
died in the hospital. Hospital mortality was highest in the
hypocapnia group (58.4 %), compared with the hypercap-
nia (56.8 %) and normocapnia (49.3 %) group (P < 0.001).
Compared with the hyperoxia (57.6 %) and normoxia
(52.9 %) groups, hospital mortality was higher (P < 0.001)
in the hypoxia group (63.6 %).
In the univariate logistic regression model, PaCO2 was
significantly associated with mortality (P < 0.001). This
model was improved when PaO2 was added (P < 0.001).
No interaction effect (arterial oxygen by arterial carbon
dioxide concentration) on mortality was found (P = 0.25).
PaO2 was also univariately associated with hospital
mortality (P < 0.001).
Adjusted outcomes
Both PaCO2 and PaO2 showed a curvilinear U-shaped
relationship with mortality in adjusted analyses (Figs. 1
and 2). Odds ratios from multivariate analyses are listed
in Table 3. After adjustment for age, lowest glucose,
AP4-adj and PaO2 (splines), hypocapnia showed a sig-
nificant association with hospital mortality (P < 0.001),
whereas hypercapnia did not. When this model was rea-
nalyzed without adjustment for PaO2, the results were
virtually unchanged (data not shown).
Adjusted for age, lowest glucose, AP4-adj and
PaCO2(splines), hypoxia but not hyperoxia was found to
be associated with hospital mortality in comparison to
normoxia (P < 0.01). When this model was reanalyzed
without adjustment for PaCO2 the results were not ma-
terially different (data not shown). When the model was
reanalyzed with hyperoxia (>300 mmHg) as reference
category, no effects on mortality were observed for various
oxygenation ranges.
The individual and joint effect estimates for derange-
ments (normal range vs. outside normal range) of both
parameters are listed in Table 4. Aberrant levels of both
PaCO2 and PaO2 were independently associated with
hospital mortality (P < 0.01). The estimate for the
interaction term (presence of PaCO2 derangement by
presence of PaO2 derangement) was not significant
on a multiplicative scale (P = 0.75).
Discussion
In accordance with previous studies, we found that early
exposure to both hypo- and hypercapnia is common in
ICU patients resuscitated from cardiac arrest [15, 16]. In
contrast, hypoxia and severe hyperoxia are uncommon
findings early in the ICU stay of Dutch hospitals. Both
PaCO2 and PaO2 had a U-shaped relationship with out-
come and after adjustment for known confounders,
hypocapnia and hypoxia were significantly associated
with hospital mortality. Hyperoxia was not independ-
ently associated with higher mortality in comparison
with various ranges for normoxia. However, this study
may lack power to detect significant associations for
severe arterial oxygen derangements considering the low
prevalence in the present cohort.
Our adjusted mortality plots and the categorized
results stress the importance of aberrant arterial levels
after cardiac arrest, but rigid cut-offs for optimal ranges
remain to be determined and validated. Increasing mor-
tality rates may be skewed towards extreme PaO2 levels
in the early phase after cardiac arrest. In line, PaCO2
levels between 40 and 45 mmHg appear to be favorable
shortly after ICU admission. The complex U-shape of
the survival curves for both parameters may explain the
heterogeneity in previously observed associations [14]. It
shows that unfavorable effects cannot be consistently
captured when the results are stratified by groups based
on arbitrary thresholds. Indeed, studies assessing arterial
hyperoxia with lower thresholds usually failed to show
significant effects on outcome, whereas higher risks were
observed with substantially higher upper limits [5–9].
The current findings validate the recent calls for caution
with hyperoxia in cardiac arrest patients only to a limited
extent. The prevalence in this cohort shows that hypoxia
and hyperoxia are not a common concern shortly after
Table 2 Unadjusted mortality rates
Outcome All
patients
PaCO2 group PaO2 group
Hypocapnia Normocapnia Hypercapnia P value Hypoxia Normoxia Hyperoxia P value
Intensive care unit mortality 2491 (47.4) 576 (50.7) 976 (42.7) 939 (51.2) <0.001 244 (58.4) 2171 (46.2) 76 (52.8) <0.001
In-hospital mortality 2833 (53.9) 663 (58.4) 1129 (49.3) 1041 (56.8) <0.001 266 (63.6) 2484 (52.9) 83 (57.6) <0.001
Data presented as total number (percentage) per group. P-values for group comparisons using Chi-squared test
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Fig. 1 Adjusted probability of in-hospital death by arterial carbon dioxide levels. Loess smoothing curve predicted from logistic regression model
adjusted for spline functions of age, lowest glucose, AP4-adj and PaO2. Grey zones represent 95 % confidence intervals
Fig. 2 Adjusted probability of in-hospital death by arterial oxygen levels. Loess smoothing curve predicted from logistic regression model adjusted for
spline functions of age, lowest glucose, AP4-adj and PaCO2. Grey zones represent 95 % confidence intervals
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cardiac arrest patients are admitted to Dutch ICUs. In the
analyses of those conditions, the relatively small number
of exposed patients increases the probability of type 2
errors. Associations are, therefore, more likely to be
consistent with increasing statistical power in the
studied subgroups. Moreover, reanalyzing the adjusted
effects of oxygenation based on quintiles did not detect a
significant association with mortality (data not shown).
Hypothesizing that physicians would avoid hypoxia most
attentively in the most critically ill patients, hyperoxia
could be an indirect marker of illness severity or respon-
sive care, and could thereby reflect a worse outcome.
Accordingly, hypoxia and hypocapnia may also be markers
of less attentive care or prehospital injury.
The absence of a significant interaction effect between
PaCO2 and PaO2 suggests that it is mainly the effect of
the individual variables that influences mortality in our
model rather than the absolute effect caused by the
interaction between the two variables. The effect of
PaO2 on hospital mortality is therefore not likely to dif-
fer significantly across strata of PaCO2, or vice versa.
Further, the effect size did not significantly depend on
the concurrent presence of aberrant arterial carbon
dioxide and arterial oxygen levels. Conditions in which
both parameters are concurrently and strongly modified
may, therefore, not synergistically increase the risk.
However, the univariate associations of PaCO2 and PaO2
were subtly altered when adjusted for each other and
both parameters should, therefore, judiciously be consid-
ered as possible confounders.
For our analyses, we were restricted to the variables
that were collected as part of the NICE registry. Our
database does not contain prehospital variables, nor does
it include all ABG samples per admission, but only a sin-
gle measurement associated with the worst oxygenation
in the first 24 h. Although this method has not previ-
ously been shown to be inferior, the selected data may
not be the most representative data over the total ICU
stay and may, therefore, misclassify patients. In addition,
selecting either the first, worst or highest value from
arterial blood gas sampling emerges as an essential
methodological issue for the intended analyses [28]. The
first measured sample may reflect pre-ICU treatment,
including oxygen administration in the ambulance and
emergency department. Early oxygen administration can
influence oxidative metabolism, respiratory markers,
vasoconstrictive status and blood flow [29–31], and may
thus be an important predictor of outcome. In fact, both
highest and lowest systolic blood pressures were signifi-
cantly higher in the hyperoxia groups. Further, hyperoxia
frequently coincides with hyperventilation and concurrent
hypocapnia [32]. Interestingly, systemic blood pressures
were very similar across the PaCO2 subgroups in this
cohort. PaCO2 could yet be an important mediator in vas-
cular effects, cardiopulmonary resuscitation and cerebral
perfusion [13, 33]. In view of that, the association between
hypocapnia and mortality may be explained by cerebral
vasoconstriction, whereas hypercapnia may be less harmful
due to increased peripheral tissue oxygenation [34–38].
Although our findings are observational and do not
necessarily imply causality, the present results are sup-
ported by previous results [5, 15]. Our findings regarding
Table 4 Associations between derangements and hospital mortality
Variable Unadjusted odds ratio (95 % CI) Adjusted odds ratio (95 % CI) P value
PaCO2 derangement vs. normocapnia 1.38 (1.24–1.54) 1.21 (1.07–1.36)
a 0.003
PaO2 derangement vs. normoxia 1.45 (1.21–1.74) 1.27 (1.05–1.54)
b 0.01
Interaction term - 1.07 (0.71–1.62) 0.75
PaCO2 derangement = PaCO2 < 35 or PaCO2 > 45 mmHg; normocapnia = PaCO2 35–45 mmHg
PaO2 derangement = PaO2 < 60 or PaO2 > 300 mmHg; normoxia = PaO2 60–300 mmHg
aMultivariable analysis adjusted for age, lowest glucose, AP4-adj and PaO2 (splines)
bMultivariable analysis adjusted for age, lowest glucose, AP4-adj and PaCO2 (splines)
CI confidence interval
Table 3 Adjusted associations between subgroups and hospital
mortality
Group comparison Odds ratio (95 % CI) P value
PaCO2 groups
Hypocapnia vs. normocapnia 1.39 (1.18–1.63)a <0.001
Hypercapnia vs. normocapnia 1.10 (0.95–1.27)a 0.20
Hypercapnia vs. hypocapnia 0.79 (0.67–0.94)a <0.01
PaO2 groups
Hypoxia vs. normoxia 1.34 (1.08–1.66)b <0.01
Hyperoxia vs. normoxia 1.13 (0.81–1.57)b 0.46
Hyperoxia vs. hypoxia 0.85 (0.58–1.24)b 0.39
Alternative PaO2 categories
c
55-80 vs. >300 mmHg 1.06 (0.76–1.50)b 0.72
80-102 vs. >300 mmHg 0.90 (0.64–1.27)b 0.55
102-300 vs. >300 mmHg 0.79 (0.56–1.11)b 0.17
Hypocapnia = PaCO2 < 35 mmHg; normocapnia = PaCO2 35–45 mmHg;
hypercapnia = PaCO2 > 45 mmHg
Hypoxia = PaO2 < 60 mmHg; normoxia = PaO2 60–300 mmHg;
hyperoxia = PaO2 > 300 mmHg
aMultivariable analysis adjusted for age, lowest glucose, AP4-adj and
PaO2 (splines)
bMultivariable analysis adjusted for age, lowest glucose, AP4-adj and
PaCO2 (splines)
cStratification based on thresholds from ARDSnet oxygenation target
(55–80 mmHg), upper threshold of median cohort quintile (102 mmHg),
and threshold from previous studies (300 mmHg)
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hyperoxia are in line with several recent studies [8, 23, 39],
even though conflicting results have been documented
[6, 7, 24, 40]. Parts of the heterogeneity in previous
findings may be attributed to the adjustment for
PaCO2. Pure oxygen therapy after cardiac arrest has
previously been shown to worsen neurological outcome in
animal models [41] and exposure to hypocapnia and
hypercapnia after ROSC has been associated with poor
neurological function at hospital discharge [16]. However,
the effects of PaO2 targets on neurological recovery of
critically ill patients are still uncertain.
In contrast to the previous study by Schneider et al.
[15], both the unadjusted and adjusted association
between mortality and hypocapnia were statistically
significant. Specific study differences may be explained
by population and methodological differences. Our
multivariate model differed slightly and there was less
dispersion of the carbon dioxide concentrations in our
data. Other notable differences between both studies
include the substantially lower median PaO2 (92 vs. 106
mmHg), mean FiO2 (58 vs. 71 %), and marginally lower
mean PaCO2 (46 vs. 44 mmHg). Furthermore, the vast
majority of patients in our cohort (80 vs. 40 %) reached
a temperature lower than 34 °C during the first 24 h of
ICU admission. Under these conditions, PaCO2 and
PaO2 progressively decrease with decreasing body
temperature and the occurrence of hypocapnia and
hypoxia may be underestimated with uncorrected ABG
levels. However, temperature correction of ABG measure-
ments is ambiguous and was not routinely performed in
our study or in the study by Schneider et al.
In order to consistently assess the relationship between
risk factors and outcome, it is important to re-evaluate
previously established associations in different populations
using robust methodology. The modified methodology of
the present study provides further insights into the
independent and combined effects of PaCO2 and
PaO2 and accounts for clustering by hospital, inter-
action effects and model variances. Still, residual con-
founding by prehospital and Utstein variables cannot
be ruled out, and derangements may not be isolated
risk factors for mortality.
Conclusions
In this multicenter cohort study, we have studied the
survival probability inferred from different levels of
PaCO2 and PaO2 in post cardiac arrest patients. Most
effects were attenuated after adjustment for identified
confounders, but hypocapnia and hypoxia were independ-
ently associated with hospital mortality. The close rela-
tionship between both parameters argues for a concurrent
assessment of the effects and further evaluation of target
ranges is warranted.
Key messages
 After resuscitation from cardiac arrest, exposure of
patients to both hypo- and hypercapnia is common
within 24 h of ICU admission
 Hypoxia and severe hyperoxia are uncommon
findings early in the ICU stay
 Both PaCO2 and PaO2 had an independent U-shaped
relationship with hospital mortality
 After adjustment for relevant confounders,
hypocapnia and hypoxia were significant predictors
of hospital mortality
 A synergistic effect of concurrent derangements of
PaCO2 and PaO2 was not observed
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